Loading clinical trials...
Loading clinical trials...
Comparison of Two FiO2 (1 or 0.5) for Tracheal Extubation in Post-anesthesia Care Unit : a Monocentric Randomized Trial
The purpose of the study is to assess the optimal fraction of inspired oxygen (0.5 or 1) for extubation or removal of a supraglottic airway device after general anesthesia.
During pre-anesthesia visit, eligible patients receive oral and written information of the study and potential risks. In the operating room all patients giving a written informed consent will undergo at the end of surgery a screening to determine eligibility for study entry. Before emergence from general anesthesia, patients who meet the eligibility requirements will be randomized in a open label manner to receive a 0.5 or 1 FiO2.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University Hospital, Caen
Caen, France
Start Date
April 9, 2021
Primary Completion Date
August 16, 2021
Completion Date
August 16, 2021
Last Updated
November 3, 2021
119
ACTUAL participants
FiO2 0.5
OTHER
FiO2 1
OTHER
Lead Sponsor
University Hospital, Caen
NCT06430957
NCT06346132
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions